Piperacillin–tazobactam combo useful for treating ESBL-producing pyelonephritis
06 Feb 2020
byJairia Dela Cruz
The combination of piperacillin plus tazobactam performs well in the management of nonbacteraemic pyelonephritis caused by extended-spectrum β-lactamase (ESBL)-producing organisms, with rates of symptom resolution and 30-day mortality similar to that achieved with carbapenem, as shown in a recent study.